Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Equities

Hims & Hers Health Q3 2025 Earnings Overview

by Team Lumida
November 4, 2025
in Equities
Reading Time: 3 mins read
A A
0
Hims & Hers Health Q3 2025 Earnings Overview
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways from Hims & Hers Health Q3 Results
Powered by lumidawealth.com

New Offerings: Expansion into low testosterone and menopause care boosting growth.
Revenue: $599 million (+49 % YoY), beating analyst expectations.
Subscribers: 2.5 million (+21 % YoY) with stronger engagement.
Average Revenue per User: $80 vs. $67 last year.
Profit: $15.8 million ( $0.06 per share ); prior-year included tax benefit.
Guidance: FY 2025 raised to $2.34 – $2.36 billion; Q4 forecast $605 – $625 million.

Telehealth company Hims & Hers Health delivered another quarter of robust growth, with Q3 2025 revenue climbing 49 % to $599 million. The figure beat Wall Street estimates as the platform continued to attract new subscribers through a widening portfolio of health-care offerings.
Net income was $15.8 million, or $0.06 per share, compared with $75.6 million ( $0.32 per share ) a year ago, when results were inflated by a $60.8 million tax benefit. Shares of HIMS were modestly lower following the report as investors digested near-term profit compression but strong underlying growth momentum.

Hims ended the quarter with 2.5 million subscribers, up 21 % year-over-year. Average monthly online revenue per subscriber increased to $80 from $67, underscoring improved monetization and customer retention.

CEO Andrew Dudum highlighted the company’s rapid expansion into new specialties such as low-testosterone therapy and menopause support, calling the demand “accelerating rapidly.” These new verticals complement Hims’s existing offerings in dermatology, mental health, and sexual wellness. The company’s data-driven, subscription-based model continues to strengthen engagement and recurring revenue.

Revenue for the quarter reached $599 million, exceeding consensus expectations of $580 million. The company’s profit decline from $75.6 million to $15.8 million reflects the absence of last year’s tax benefit rather than operational weakness.

For FY 2025, Hims raised its revenue guidance to $2.34 billion – $2.36 billion, compared with $2.3 billion – $2.4 billion previously. For Q4, management expects $605 million – $625 million in revenue, slightly below analysts’ $631.7 million consensus. Continued subscriber additions, higher per-user spend, and category expansion are expected to drive steady growth despite short-term margin pressure.

Source
Previous Post

Palantir Revenue Climbs to Another Record as Defense Work Booms

Next Post

Travel Industry Sounds Alarm Over Government Shutdown

Recommended For You

Fox Profit Jumps to $957 Million as the World Cup and a Record $350 Million in Midterm Political Ads Lift Revenue 22% to $4.57 Billion, Topping Estimates

by Team Lumida
2 hours ago

Fox’s fiscal Q1 profit rose to $957M as the World Cup and midterm ads drove a 47% jump in ad revenue, while CEO Lachlan Murdoch played down a...

Read more

Inflation Talk Returns to Earnings Calls: S&P 500 Executives Are On Track for More Than 1,100 Mentions, the Biggest Jump Since the 2022 Price Shock

by Team Lumida
2 hours ago
Election Day Countdown: Inflation Data Rocks Markets

S&P 500 executives are on track to mention inflation more than 1,100 times this earnings season, the biggest jump since 2022, as margins come under pressure.

Read more

Trump Family-Linked Tungsten Miner Kaz Resources Plans a $2 Billion Direct US Listing, Backed by Letters of Interest for Up to $1.6 Billion in US Funding

by Team Lumida
2 hours ago

Kaz Resources, a tungsten miner with ties to two of President Trump’s sons, plans a direct US listing next year in a proposed $2 billion deal.

Read more

Marvell Makes a $115 Billion All-Stock Bet on Optical AI Networking With a Deal for Lumentum, Offering 4.5 Shares for Each Lumentum Share

by Team Lumida
2 hours ago
Marvell Technology Earnings Highlights: Strong AI-Driven Growth and Positive Outlook

Marvell will buy Lumentum in an all-stock deal valuing it at a $115B enterprise value, betting that AI data centers are shifting to optical connectivity.

Read more

Amgen Bets Its Obesity Push on MariTide Ahead of Tuesday’s Earnings, With Analysts Seeing $6 Billion in Annual Sales by 2035

by Team Lumida
10 hours ago

Amgen faces questions at Tuesday’s earnings on whether MariTide, its monthly obesity shot, can stand out against Lilly and Novo in a $120 billion market.

Read more

AbbVie Beats by 9 Cents as Immunology Sales Jump 16% to $9.17 Billion, Lifting Its Profit Outlook and Raising Its Dividend 5.2% to $1.82

by Team Lumida
3 days ago

AbbVie’s Q3 revenue rose 10% to $17.4 billion on Skyrizi and Rinvoq, and it raised full-year guidance above Wall Street’s forecast.

Read more

BofA Downgrades Intel as Five Firms Cut Price Targets After Its Guidance Miss, While Jefferies Upgrades Rivian and Morgan Stanley Keeps Amazon as a Top Pick

by Team Lumida
3 days ago

BofA cut Intel to neutral as four other firms slashed targets, while Jefferies upgraded Rivian and HSBC lifted GE Vernova to buy on Friday.

Read more

Exxon’s Profit Doubles to $15.4 Billion and Chevron’s Jumps Nearly 200% as a Global Diesel Crunch Turns Refining Into Their Biggest Earner

by Team Lumida
3 days ago

Exxon earned $15.4 billion and Chevron $9.9 billion in Q3 as US Gulf Coast refineries ran flat out to fill a global diesel shortage.

Read more

Reddit Sinks 18% After Hours on Soft Guidance as Google’s AI Search Cuts Referral Traffic, Pushing It to Test Mandatory Logins

by Team Lumida
3 days ago

Reddit beat Q3 estimates, but its Q4 sales guide missed, US daily users fell 2%, and it will test requiring users to log in.

Read more

Intel Plunges About 21% After Hours as Weak Fourth-Quarter Guidance and a PC Slowdown Overshadow 78% Data Center Growth

by Team Lumida
3 days ago
Intel Surges 5%, SK Hynix Up 3% on Reports of U.S. Memory Chip Manufacturing Deal to Serve Nvidia and AI Demand

Intel guided Q4 revenue to $15 billion to $16 billion versus $17.1 billion expected and warned the PC slowdown will last into 2027.

Read more
Next Post
airplanes window view of sky during golden hour

Travel Industry Sounds Alarm Over Government Shutdown

China’s Bold Economic Moves: What You Need to Know Now

China Urges US to Avoid ‘Red Lines’ After Trade Truce

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

person holding silver iPhone X

No More Android: Microsoft Mandates iPhones for Chinese Employees

July 8, 2024
Bitcoin Could Drop to $50K Before a Potential Fed-Driven Rally

Guggenheim Revolutionizes Finance: $20M Tokenized on Ethereum

September 26, 2024
high rise buildings during daytime

Commercial Real Estate Risks Trigger Potential Downgrades for These US Banks

June 10, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bank of America China Commercial Real Estate CPI data centers Donald Trump EARNINGS ELON MUSK Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Novo Nordisk Nuclear Energy Nvidia oil OpenAI private equity S&P 500 SEC Semiconductor stock market stock surge Tech Stocks tesla Trump Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018